Related Experiment Video
Updated: Jun 16, 2026

Expression, Detergent Solubilization, and Purification of a Membrane Transporter, the MexB Multidrug Resistance Protein
Published on: December 3, 2010
Outer membrane protein I of Pseudomonas aeruginosa is a target of cationic antimicrobial peptide/protein
Yu-Min Lin1, Shih-Jung Wu, Ting-Wei Chang
1Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan.
Abstract:
Cationic antimicrobial peptides/proteins (AMPs) are important components of the host innate defense mechanisms against invading microorganisms. Here we demonstrate that OprI (outer membrane protein I) of Pseudomonas aeruginosa is responsible for its susceptibility to human ribonuclease 7 (hRNase 7) and alpha-helical cationic AMPs, instead of surface lipopolysaccharide, which is the initial binding site of cationic AMPs. The antimicrobial activities of hRNase 7 and alpha-helical cationic AMPs against P. aeruginosa were inhibited by the addition of exogenous OprI or anti-OprI antibody. On modification and internalization of OprI by hRNase 7 into cytosol, the bacterial membrane became permeable to metabolites. The lipoprotein was predicted to consist of an extended loop at the N terminus for hRNase 7/lipopolysaccharide binding, a trimeric alpha-helix, and a lysine residue at the C terminus for cell wall anchoring. Our findings highlight a novel mechanism of antimicrobial activity and document a previously unexplored target of alpha-helical cationic AMPs, which may be used for screening drugs to treat antibiotic-resistant bacterial infection.
Insights
Pseudomonas aeruginosa outer membrane protein I (OprI) mediates susceptibility to human ribonuclease 7 (hRNase 7) and other cationic antimicrobial peptides (AMPs). This discovery reveals a new target for developing drugs against antibiotic-resistant bacteria.
Area of Science:
- Microbiology and Immunology
- Bacterial Pathogenesis
- Antimicrobial Drug Discovery
Background:
- Cationic antimicrobial peptides/proteins (AMPs) are crucial for innate immunity against microbial infections.
- Pseudomonas aeruginosa is a significant opportunistic pathogen, often exhibiting antibiotic resistance.
- Lipopolysaccharide (LPS) is typically considered the primary binding site for cationic AMPs on Gram-negative bacteria.
Purpose of the Study:
- To identify the specific target of human ribonuclease 7 (hRNase 7) and alpha-helical cationic AMPs on Pseudomonas aeruginosa.
- To elucidate the mechanism by which OprI influences bacterial susceptibility to these antimicrobial agents.
- To explore OprI as a potential therapeutic target for combating antibiotic-resistant infections.
Main Methods:
- Investigated the role of outer membrane protein I (OprI) in P. aeruginosa susceptibility to hRNase 7 and alpha-helical cationic AMPs.
- Assessed the inhibitory effects of exogenous OprI and anti-OprI antibodies on antimicrobial activity.
- Analyzed the consequences of OprI modification and internalization by hRNase 7 on bacterial membrane permeability and metabolite leakage.
- Predicted the structural features of OprI involved in binding and anchoring.
Main Results:
- Outer membrane protein I (OprI), not lipopolysaccharide, was identified as the key factor determining P. aeruginosa susceptibility to hRNase 7 and alpha-helical cationic AMPs.
- Antimicrobial activity was significantly inhibited by the presence of OprI or antibodies targeting OprI.
- hRNase 7-mediated modification and internalization of OprI led to increased bacterial membrane permeability and metabolite release.
- OprI possesses structural elements, including an N-terminal loop and a C-terminal lysine, facilitating binding and anchoring.
Conclusions:
- OprI represents a novel target for alpha-helical cationic AMPs, offering a new mechanism of antimicrobial action against P. aeruginosa.
- Targeting OprI could be a viable strategy for developing new therapeutics against antibiotic-resistant bacterial infections.
- These findings challenge the traditional view of LPS as the sole initial binding site for cationic AMPs.
More Related Videos
Related Concept Videos
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Inhibitors of Gram-positive Cell Wall Synthesis
Structure of Porins
Antifungal Agents
Multi-pass Transmembrane Proteins and β-barrels
α-Helix containing multi-pass transmembrane proteins
Multi-pass transmembrane proteins such as G-protein-linked receptors (GPCRs) and...
Mechanism of Antibiotic Resistance in MRSA

